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Abstract: 
Objective: Cardiopulmonary exercise testing (CPET) is the “gold standard” method of 
determining VO2peak. When CPET is unavailable, VO2peak may be estimated from 
treadmill or cycle ergometer workloads and expressed as estimated metabolic 
equivalents (METs). Cardiac rehabilitation (CR) programmes use estimated VO2peak 
(METs) to report changes in cardiorespiratory fitness (CRF). However, the accuracy of 
determining changes in VO2peak based on estimated functional capacity is not known. 
 
Methods: 27 patients with coronary heart disease (88.9% male; age 59.5 ± 10.0 years, 
body mass index 29.6 ± 3.8 kg
.
m
-2
) performed maximal CPET before and after an 
exercise-based CR intervention. VO2peak was directly determined using ventilatory gas 
exchange data and was also estimated using the American College of Sports Medicine 
(ACSM) leg cycling equation. Agreement between changes in directly determined 
VO2peak and estimated VO2peak was evaluated using Bland-Altman limits of agreement 
(LoA), and intraclass correlation coefficients.  
 
Results: Directly-determined VO2peak did not increase following CR (0.5 ml
.
kg
-1.
min
-1
 
(2.7%); p=0.332). Estimated VO2peak increased significantly (0.4 METs; 1.4 ml
.
kg
-1.
min
-1
; 
6.7%; p=0.006). The mean bias for estimated VO2peak versus directly-determined 
VO2peak was 0.7 ml
.
kg
-1.
min
-1
 (LoA -4.7 to 5.9 ml
.
kg
-1.
min
-1
). Aerobic efficiency, 
(ΔVO2/ΔWR slope) was significantly associated with estimated VO2peak measurement 
error. 
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Conclusion: Change in estimated VO2peak derived from the ACSM leg cycling equation 
is not an accurate surrogate for directly-determined changes in VO2peak. Our findings 
show poor agreement between estimates of VO2peak and directly-determined VO2peak. 
Applying estimates of VO2peak to determine CRF change may over-estimate the efficacy 
of CR and lead to a different interpretation of study findings. 
 
Key Words: Coronary Heart Disease, Cardiac Rehabilitation, Exercise Testing, 
Cardiopulmonary Exercise Testing, Metabolic Equivalents, METs, Estimated VO2peak, 
VO2peak   
 
Clinicaltrial.gov identifier: NCT01761448 
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Introduction 
 
Structured exercise training is a core component of most cardiac rehabilitation (CR) 
programmes (Anderson, et al. 2016; BACPR 2012; Heran, et al. 2011; Taylor, et al. 
2006). The efficacy of exercise-based CR is predicated on appropriately personalised 
exercise training (Uddin, et al. 2015). Exercise prescriptions should be based on an 
individualised assessment that includes an initial exercise test. Maximal 
cardiopulmonary exercise testing (CPET) is the “gold standard” method for 
determining cardiorespiratory fitness [CRF] (Mezzani, et al. 2013). Information 
obtained during CPET provides some of the most accurate data on which to base an 
exercise prescription and to determine changes in CRF following the completion of a 
CR programme.  
 
Where CPET is not available, workloads achieved during an incremental exercise test 
(on treadmill or cycle ergometry) may be used to estimate VO2peak (ACSM 2013; 
Buckley, et al. 2016). Estimates of VO2peak are commonly expressed as estimated 
metabolic equivalents (METs). Although recently challenged (Buckley, et al. 2016) 
equations for estimating VO2peak and METs are traditionally based on an assumed 
linear relationship between VO2 and work rate (ACSM 2013). Despite contradictory 
evidence, (Byrne, et al. 2005) one MET (corresponding to resting metabolic rate) is 
widely accepted to equate to a VO2 of 3.5 ml
.
kg
-1.
min
-1 
(Wasserman, et al. 2011). 
Changes in estimated functional capacity during an exercise test are commonly 
expressed in multiples of resting metabolic rate. This metric allows comparisons of 
participant results from exercise testing undertaken using estimated versus direct 
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determinated VO2peak. Peak estimated METs achieved during maximal exercise testing 
are used to risk-stratify patients, prescribe individual exercise intensities for exercise 
training, and to determine changes in CRF following exercise interventions (ACPICR 
2015). However, estimates of functional capacity may not accurately quantify VO2peak, 
particularly during treadmill protocols (Milani, et al. 1995; Myers, et al. 1991; 
Pinkstaff, et al. 2011). Whilst the limitations of estimating VO2peak from a single 
exercise test are known, the accuracy of estimated changes in VO2peak following an 
exercise training intervention is unclear.  
 
Large discrepancies between estimated, and directly determined VO2peak have 
previously been reported (Froelicher, et al. 1984; Kavanagh, et al. 2002). However, to 
our knowledge, the only relevant investigation examining the suitability of estimating 
VO2peak change from peak METs found no significant correlation (r=0.24) in 50 patients 
with coronary heart disease (CHD) undertaking maximal treadmill testing (Milani et al. 
1995). Stuto, et al. (2013) also present data showing that the increase in directly 
determined VO2peak (14.7%) was not accurately reflected by a much lower 
improvement in functional capacity (3.85%) following CR. Thus, in this elderly cohort 
of patients attending CR, change in estimated peak METs did not appear to reflect 
improvement in directly determined VO2peak. However, this was not specifically 
addressed by Stuto, et al. (2013). We therefore aimed to investigate the accuracy of 
estimating changes in VO2peak using the American College of Sports Medicine (ACSM 
2013) leg cycling equation in patients with CHD.  
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Methods 
 
Study design  
Ethical approval was provided by the Yorkshire and the Humber NHS Research Ethics 
Committee (12/YH/0072). All patients provided written informed consent. All patients 
had agreed to participate in routine CR as delivered by their local National Health 
Service provider, and were a minimum of 28 days’ post cardiac event at the time of 
baseline assessment (Visit 1). Patients were included if they had completed maximal 
CPET before (visit 1) and following the completion of their CR exercise programme 
(visit 2). Clinical information collected included cardiac diagnosis, past medical history, 
medications, smoking status, resting heart rate, blood pressure, waist circumference 
measurement, and body mass index (BMI). Ejection Fraction (EF) was determined 
from a resting echocardiogram. Patients with New York Heart Failure Classification 
(NYHA) IV, a left ventricular ejection fraction <30%, or a pacemaker/implantable 
cardioverter defibrillator, were excluded. 
 
Cardiac Rehabilitation Programme  
Patients were recruited from four different CR centres in Yorkshire and Northern 
Lincolnshire (UK) between January and March 2013. CR provision remains inequitable 
across the UK (Brodie, et al. 2006; Doherty & Lewin 2012). The diversity of practice 
was reflected by the characteristics of the CR programmes included in this study. All 
CR programmes used interval circuit training with alternating cardiovascular and 
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active recovery exercises. Exercise was prescribed at 40-70% of estimated heart rate 
reserve [HRR] using formulae recommended by the Association of Chartered 
Physiotherapist in Cardiac Rehabilitation (ACPICR 2015). The programme length varied 
from 4-24 sessions conducted over a 4-12 week period. The median number of 
exercise sessions during follow up was 15 (range: 0 to 62). 
 
Cardiopulmonary Exercise Testing 
At baseline and after completion of training, patients undertook a CPET to volitional 
exhaustion or limiting symptoms following a 25W, two-minute stage, incremental 
electronically-braked cycle ergometer protocol (GE Healthcare e-Bike, Chalfont St 
Giles, United Kingdom). Patients started pedalling at 25W without a prior unloaded 
cycling phase. Breath-by-breath metabolic gas measurements were collected via an 
Innocor (Innovision, Glamsbjerg, Denmark) metabolic cart.  Calibration was performed 
prior to each exercise test according to the manufacturer’s instructions. ECG and heart 
rate (HR) were continuously recorded using a GE Case System (GE Healthcare, 
Chalfont St Giles, United Kingdom) BP was monitored at two minute intervals using a 
Tango automated sphygmomanometer (SunTech Medical, Eynsham, United Kingdom). 
Exercise was terminated if a patient experienced chest pain or achieved any of the 
test termination criteria outlined by the American Thoracic Society (2003). Data were 
exported as breath-by-breath values and post-processed to generate 15 second 
averages using Microsoft Excel (Microsoft, Redmond WA, USE). VO
2peak and peak 
respiratory exchange ratio (RER) were both averaged over the final 30 seconds of 
CPET. VO2peak was standardised to body mass and reported as (ml
.
kg
-1.
min
-1
). The 
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ventilatory anaerobic threshold (VAT) was determined using the V-slope method 
(Beaver, et al. 1986) and also reported standardised to body mass. The slope of VO2 as 
a function of work rate (ΔVO2/ΔWR slope), a measure of aerobic efficiency, was 
determined using linear regression from data obtained throughout the CPET. 
ΔVO2/ΔWR slope values <8.4 mL/min
-1
/W were considered abnormal (Wasserman, et 
al. 2011). Estimated peak METs were calculated using the ACSM (2013) leg cycling 
equation:  
VO2 = (1.8 x kg
.
m
.
min
-1
) / BM + (7.0) 
Where kg
.
m is Kilogram metres (and where 1W is equal to 6.12 kg
.
m
.
min
-1
) and BM is 
patient body mass. The term ‘directly-determined’ VO2peak and ‘estimated VO2peak’ are 
used to distinguish between the two variables.  
Patients were asked to rate their perceived exertion (RPE) at the end of every two-
minute stage during and at peak exercise using the 6-20 Borg score (Borg, 1982). 
Instructions for the use of the Borg score were given to patients prior to CPET using a 
standardised list of terms.  
 
Statistical Analysis 
Statistical analysis was performed using SPSS version 22 (IBM, New York, USA). Data 
were visually assessed for normality and heteroscedasticity. Categorical data are 
reported as percentages. Continuous normally distributed variables are displayed as 
mean with 95% confidence intervals (95% CI) or standard deviation (±) where 
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specified. Statistically significant differences (p < 0.05) were calculated using repeated 
measures analysis of variance (ANOVA) and repeated measures analysis of covariance 
(ANCOVA). Partial eta
2
 
(ηp
2
) effect sizes were also calculated with 0.01, 0.06 and 0.14 
representing small, medium, and large effect sizes respectively (Richardson, 2011). 
Pearson correlations were used to assess the strength of the relationship between 
variables. An r value of <0.25, 0.26 to 0.50, 0.51 to 0.75, and, >0.75 were considered 
weak, moderate, fair and strong associations, respectively (Berg & Latin 2008). 
Intraclass correlation coefficients (ICC) and Bland-Altman analysis were used to assess 
agreement between measurement methods (Atkinson & Nevill 1998; Bland & Altman 
1999). The maximum acceptable difference between assessment methods was set at 
3.5 ml
.
kg
-1.
min
-1
 (1 MET). A recent sampling of studies expressing exercise capacity in 
terms of survival benefit, showed that a 1 MET increase in CRF (including estimated 
functional capacity or directly-determined VO2) carried significant survival benefits in 
both healthy adults and patients with CHD [ranging from 8-35%] (Ross, et al. 2016). 
Further, the AHA scientific statement on importance of assessing CRF in clinical 
practice refers to a 1 MET improvement as a clinically significant improvement in CRF 
(Ross, et al. 2016). A measurement error greater than 1 MET would not only suggest 
that estimates of VO2peak do not reliably interpret patient risk, but also that they are 
poor markers for monitoring CRF change.  A consensus on ICC strength has not been 
reached, but we defined moderate agreement as an ICC of 0.6–0.75, good agreement 
between 0.75 and 0.9 and excellent >0.9 (Atkinson & Nevill 1998). 
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Results 
 
Patient Characteristics  
 
Patient characteristics and medications at baseline are reported in Table 1. n=44 
patients conducted a baseline maximal CPET. n=17 were lost to follow-up. n=27 were 
included for analysis. (88.9% male; age 59.5 ± 10.0 years, body mass index [BMI] 29.6 
± 3.8 kg
.
m
-2
). The median number of exercise sessions conducted at follow up was 15 
(range: 0 to 62). Five patients failed to attend at least one exercise session. 
 
 
Cardiorespiratory Fitness Changes 
 
Table 2 shows changes in key CPET variables. Despite a significant increase in exercise 
test duration and peak power output [watts], there was no significant change in 
directly-determined VO2peak (mean change: 2.7%; 0.5 ml
.
kg
-1.
min
-1
; 95% CI: -0.6 to 1.8 
ml
.
kg
-1.
min
-1
). There were no significant changes in peak HR or RPE (indicators of 
patient effort) between CPETs. Peak RER, however, was significantly higher at visit 2 
compared to visit 1. Change in directly determined VO2peak remained non-significant 
when RER change was considered as a covariate (mean change 0.6 ml
.
kg
-1.
min
-1
; 95% 
CI: -0.6 to 1.8 ml
.
kg
-1.
min
-1
 p=0.324).  
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Consistent with the increased workload, there was a significant increase in estimated 
functional capacity or peak METs (mean change: 6.7%; 0.4 METs; 95% CI: 0.1 to 0.6 
METs). This corresponded to an estimated VO2peak change of 1.4 ml
.
kg
-1.
min
-1
. The VAT 
(mean change: 9.9%; 1.4 ml
.
kg
-1.
min
-1
;
 
95% CI: 0.5 to 2.3 ml
.
kg
-1.
min
-1
), and ventilatory 
efficiency slope (VE/VCO2 slope) also significantly improved following CR. The mean 
ΔVO2/ΔWR slope was within normal limits at both visits and did not change 
significantly between visits. However, 19% (n=10) of all exercise tests had a 
ΔVO2/ΔWR slope below the lower limit of normal (<8.4 mL/min/W).  
 
Agreement between Directly-Determined VO2peak and Estimated VO2peak  
 
Correlations and measures of agreement for CPET variables are presented in Table 3. 
There was a significant association between directly determined VO2peak and 
estimated VO2peak on both pre and post- cardiac rehabilitation visits (Figure 1A and 1 
B). The mean bias and limits of agreement for estimated VO2peak on both tests are also 
presented in Table 3. The association between changes in directly-determined VO2peak 
and estimated VO2peak was substantially reduced (Figure 1C, r=0.527, p=0.05). The ICC 
between the two measurements was not non-significant (ICC 0.358; 95% CI -0.442 to 
0.711; p=0.138).  
Bland-Altman Analysis (Figure 2) showed the mean bias for changes in VO2peak was less 
than the maximal acceptable difference (0.7 ml
.
kg
-1.
min
-1
; 95% CI -0.4 to 1.8 ml
.
kg
-
1.
min
-1
; p=0.178; ηp
2
= 0.069). However, the limits of agreement (LoA) were 
considerably wider (-4.7 to 5.9 ml
.
kg
-1.
min
-1
; lower LoA 95% CI: -5.1 to -4.3; upper LoA 
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95% CI: 5.5 to 6.3 ml
.
kg
-1.
min
-1
). VO2peak measurement error was higher than the 
maximal clinically acceptable difference in 33% of participants. There was
 
a significant, 
moderate negative correlation between VO2peak measurement error (estimated 
VO2peak minus directly determined VO2peak) and the ΔVO2/ΔWR slope at visit 1 and 2 
(Figure 3, r=-0.496, p<0.001).  
 
Discussion 
 
Estimated METS derived from the ACSM leg cycling equation are significantly and 
consistently associated with directly-determined oxygen consumption in a 
representative cohort of patients attending CR. However, the LoA from our Bland-
Altman analysis suggest that changes in estimated functional capacity do not 
accurately reflect directly determined VO2peak changes following a CR exercise training 
intervention. This is supported by our failure to find a significant ICC between the two 
measurements. 
 
Increasing VO2peak through structured exercise training improves survival (Vanhees, et 
al. 1995) in patients with CHD and, consequently, improving VO2peak remains a key 
objective for CR practitioners. Practitioners need to have confidence in the efficacy of 
the outcome measures they report. Given that CR programme outcome data from 
functional capacity testing are often expressed in estimated METs, there is a 
requirement to examine the suitability of estimated functional capacity to accurately 
reflect changes in VO2peak.  
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Significant mean improvements in peak exercise time, power output and associated 
improvements in estimated METs following cardiac rehabilitation were not 
accompanied by improved mean peak oxygen consumption in the present study. 
These findings question the appropriateness of using estimated VO2peak (METs) as a 
surrogate indicator of improvements in VO2peak. Reporting estimated METs alone may 
lead to inaccurate interpretations of the efficacy of exercise interventions within 
rehabilitation settings. 
 
Estimating mean changes in VO2peak (through widely applied MET equations) over 
predicted actual VO2peak by more than two-fold in this patient group. These findings 
are consistent with previously published data (Froelicher, et al. 1984; Milani, et al. 
1995) which indicate poor agreement between estimates of VO2peak change and 
directly determined VO2peak change. However, our findings contradict those of Stuto 
and colleagues (2013) who described a lower relative improvement in functional 
capacity (3.85%) compared to directly determined VO2peak (14.7%). The limited 
information provided within this study abstract limits comparison of the study 
findings. However, these findings may have important implications when interpreting 
the CRF benefits of CR.  
  
Improvements in other CPET components of cardiorespiratory fitness were observed 
following exercise training in this cohort. The VAT significantly increased following 
exercise-based CR. Improvements in VAT are associated with increased endurance 
capacity, less blood lactate accumulation and associated acid-base metabolic 
perturbations (Ghosh 2004; Sullivan, et al. 1989). Given VO2peak remained unchanged, 
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changes in the VAT are likely to have contributed to improved exercise capacity and 
estimated MET changes. 
  
The failure of estimated MET change to accurately predict directly determined VO2peak 
change may in part, be attributed to test familiarisation and improved movement 
economy leading to a longer test duration (Fletcher, et al. 2001; Russell, et al. 1998). 
However, the use of a cycle ergometer as opposed to a treadmill may partially 
mitigate these influences. It is possible that the use of our step protocol (2 minute 
stages, 25W Increments) may have led to a weaker association between VO2 and work 
rate. Two minutes may have been inadequate time to attain VO2 steady-state, 
especially in patients with CHD. Less predictable VO2/work rate relationships have 
been observed in patients with cardiovascular disease. Poor oxygen uptake kinetics 
resulting from poor muscle oxygen extraction, myocardial dysfunction, chronotropic 
incompetence and β-blockade all have the potential to influence the VO2/work rate 
relationship (Belardinelli, et al. 2003; Brubaker & Kitzman 2011; Hughson 1984; 
Mezzani, et al. 2009; Poole, et al. 2012). Indeed, approximately one fifth of the 
maximal CPET’s conducted demonstrated poor aerobic efficiency (ΔVO2/ΔWR slope 
<8.4 mL/min/W). ΔVO2/ΔWR slope was negatively correlated with estimated VO2peak 
measurement error (r=-0.496, p<0.001) indicating that estimates of VO2peak over-
predict directly determined VO2peak when patients are aerobically ‘inefficient’. 
Inefficient cardiometabolic responses to exercise resulting in delayed oxygen kinetics, 
may also prolong dependence on anaerobic metabolism (Mezzani, et al. 2009) during 
sequential work rate transitions. In such instances, the assumptions of linearity 
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between work rate and VO2 would not apply and work rate would therefore not be 
indicative of VO2.  
 
This issue of the VO2-work rate relationship is particularly pertinent above the VAT 
where VO2 steady-state attainment can take up to 15 minutes due to the presence of 
a VO2 slow component. Steady state attainment above critical power, i.e. near peak 
exercise, is not achieved (Mezzani, et al. 2013). With this in mind, it is doubtful that 
any practical CPET protocol is truly capable of predicting VO2 based on workload 
alone. Accurately estimating VO2peak , moreover VO2peak changes in CHD patients, as 
evidenced by our findings and others (Froelicher, et al. 1984; Milani, et al. 1995; Stuto, 
et al. 2013), poses significant challenges, particularly at an individual patient level.  
 
Assessing functional capacity (by estimating METs) remains useful in the broad 
classification of baseline cardiorespiratory fitness and prognostic risk classification 
among participants attending for cardiac rehabilitation (Taylor, et al. 2016). However, 
poor agreement between estimated and directly-determined changes in VO2peak 
questions the validity of this “widely used metric” when reporting CRF changes within 
CR settings. Our data require further validation in larger samples of cardiac 
rehabilitation patients. Practitioners should explore opportunities to integrate 
scientifically robust exercise testing techniques, such as CPET, in demonstrating 
clinically meaningful improvements in CRF outcomes from exercise rehabilitation.  
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Variable  All Patients 
Participants n=27 
Sex (% male) n=24 (88.9) 
Age (Years) 59.5 ± 10.0 
BMI (kg
.
m
-2
) 29.6 ± 3.8 
Waist Circumference 
(cm) 106.1 ± 10.0 
LVEF (%) 58.9 ± 9.2 
SBP (mmHg) 140 ± 19 
DBP (mmHg) 83 ± 10 
HR (bpm) 60 ± 7 
    
MI (%) n=16 (59.3) 
PCI (%) n=10 (37.0) 
CABG (%) n=1 (3.7) 
PMH MI (%) n=12 (44.4) 
PMH CABG (%) n=3 (11.1) 
    
Type 2 Diabetes (%) n=5 (18.5) 
Asthma (%) n=1 (3.7) 
COPD (%) n=2 (7.4) 
Atrial Fibrillation (%) n=3 (11.1) 
Smoking (%) n=4 (14.8) 
    
Aspirin (%) n=26 (96.2) 
Ticagrelor (%) n=10 (37.0) 
Clopidogrel (%) n=15 (55.6) 
Beta-Blocker (%) n=22 (81.5) 
ACE-Inhibitor (%) n=16 (59.3) 
Statin (%) n=26 (96.2) 
 
Table 1 – Patient Characteristics and Medication  
BMI = Body Mass Index; EF = Ejection Fraction; SBP = Systolic 
Blood Pressure; DBP = Diastolic Blood Pressure; HR = Resting HR; 
MI = Myocardial Infarction; PCI = Percutaneous Coronary 
Intervention; CABG = Coronary Artery Bypass Graft; PMH = Past 
Medical History; COPD = Chronic Obstructive Pulmonary Disease; 
ACE = Angiotensin Converting Enzyme
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  Visit 1  (±SD) 
Visit 2 (±SD) Mean Change (95% 
CI) 
P-Value ηp
2 
 
VO2peak                         
(ml·kg
-1
·min
-1
) 
21.9 ± 7.6 22.5 ± 7.2  0.5 (-0.6 to 1.8) 0.332 0.036 
Estimated VO2peak 
(ml·kg-1·min-1) 
20.9 ± 6.4 22.2 ± 6.7 1.3 (0.4 to 2.2) 0.006* 0.254
ǂ
 
Estimated peak 
METs 
6.0 ± 1.8 6.4 ± 1.9 0.4 (0.1 to 0.6) 0.006* 0.254
ǂ
 
Exercise Test 
Duration (Sec) 
585.4 ± 228.1 651.8 ± 250.0 66.4 (9.9 to 122.9) 0.023* 0.184
ǂ
 
Peak Watts 111.1 ± 49.2 118.5 ± 48.8 7.4 (1.4 to 13.4) 0.018* 0.198
ǂ
 
VO2 at VAT       
(ml·kg
-1
·min
-1
) 
14.1 ± 4.5 15.5 ±  5.3  1.4 (0.5 to 2.3) 0.005* 0.276
ǂ
 
ΔVO2/ΔWR slope 10.2 ± 2.0 10.2 ± 2.1 0.1 (-0.7 to 0.9) 0.829 0.002 
VE/VCO2 slope 32.1 ± 6.9 28.9 ± 5.8 -3.2 (-5.0 to -1.3) 0.002* 0.321
ǂ
 
Peak RER 1.02 ± 0.09 1.06 ± 0.7 0.04 (0.2 to 0.07) 0.002* 0.330
ǂ
 
Peak HR (bpm) 130 ± 25 129 ± 24 -1 (-6 to 4) 0.714 0.005 
Peak Borg Score 17.7 ± 2.1 16.9 ± 2.6 -0.8 (-2.1 to 0.4) 0.192 0.064 
Peak SBP (mmHg) 182 ± 26 185 ± 22 3 (-6 to 12) 0.485 0.019 
Peak DBP (mmHg) 90 ± 14 97 ± 14 6 (0 to 12) 0.037* 0.157 
 
Table 2 - Cardiorespiratory Fitness Changes   
VO2peak = Peak Oxygen Uptake; VAT = Ventilatory Anaerobic Threshold; VE/VCO2 = Ventilatory Efficiency with Respect to CO2 Elimination; 
ΔVO2/ΔWR slope = Change in Oxygen Uptake Vs. Change in Work Rate slope; RER = Respiratory Exchange Ratio; HR = Heart Rate; BPM = 
Beats per Minute; SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; sec=seconds; METs = Metabolic Equivalents 
*= statistically significant; ǂ = Large Effect Size 
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  Correlation (r) 
Mean Bias 
(ml
.
kg
-1.
min
-1
) 
LoA (ml
.
kg
-
1.
min
-1
) 
ICC (95% CI) 
VO2peak Vs. Estimated 
VO2peak at Visit 1 
0.958* -1 .0* -5.6 to 3.6 
0.967 (0.921 to 
0.986)* 
VO2peak Vs. Estimated 
VO2peak at Visit 2 
0.945* 0.3 -4.8 to 4.3 
0.971 (0.936 to 
0.987)* 
Change in Estimated 
VO2peak Vs. Measured 
VO2peak  
0.527* 0.7 -4.6 to 5.9 
0.358 (-0.442 to 
0.711) 
Table 3 – Measures of Agreement between Measured and Estimated VO2peak   
r = Correlation Coefficient; LoA = Limits of Agreement; ICC = Intraclass Correlation; VO2peak = Peak Oxygen Uptake 
*= Statistically Significant 
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Figure 1 – Correlations showing the relationship between directly 
determined VO2peak and estimated VO2peak for visit 1 (panel A; r = 
0.958, p<0.001) and visit 2 (panel B; r=0.945, p<0.001) Panel C shows 
correlation between directly determined VO2peak change and 
estimated VO2peak change between visit 1 and 2 (r=0.527, p<0.05).   
VO2peak = peak oxygen uptake 
 
A 
B 
C 
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For Peer ReviewFigure 3 – Bland-Altman plot showing mean bias (0.7 ml.kg-1.min-1), LoA (-4.6.3 to 5.9 ml.kg-1.min-1) with 95% CI (grey shaded area).  
VO2peak = peak oxygen uptake 
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Figure 4 – Correlation showing a significant, moderate negative correlation between ΔVO2/ΔWR slope and 
estimated VO2peak measurement error 
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